Pharmaceutical Executive - Pharmaceutical news and analysis. Pharma management, sales, marketing & finance

ADVERTISEMENT

Previous Story Play / Pause Next Story
New & Noteworthy
The 2013 Pharm Exec Top 50
Patent expiries dampen revenues for some of the biggest Big Pharma, but growth continues unabated for a few nimble "stealth" players moving steadily up the list.
The Big Squeeze
New approaches to managing reimbursements for pharmacy benefit programs are testing Big Pharma.
Wanted: A Trusted Advisor
Al Topin on redefining your ad agency's role in today's complex pharma market

Latest Pharm Exec Videos

Events
9th Commercial Contracts and Chargeback Management
June 19, 2013 - June 20, 2013
Philadelphia, PA USA

CBI's Orphan Drug Innovation Summit 2103
July 17, 2013 - July 18, 2013
Philadelphia, PA USA

Clinical Data Analytics
July 17, 2013 - July 18, 2013
Philadelphia, PA USA

CPhI Worldwide
October 22, 2013 - October 24, 2013
Frankfurt, Germany

The Myriad Ruling: Six Points Every Biotech CEO Must Consider
Brand/Generic Patent Settlements Become More Risky
Helping Patients Lead the Way in the New NHS
2013: The Year of Mobile Health
Myriad Decision: Praise and Perils for Biotechnology Patent Policy
England's Latest Innovation Scorecard: A Patchy Picture
Regulatory Tom NortonYour 2014 Medicaid Sales and Marketing Plans
Social Media & Marketing Peter HoustonShould Pharma Do Tumblr?
Europe ReflectorFirst "Real" European Patent Imminent
Global Leela BarhamThe UK's "Revolutionary" New Medicines Optimization Plan
 More
Survey
How important is it for pharmaceutical marketers to monitor what their customers are saying on social media?
Highly important
Somewhat important
Not important
Highly important
81%
Somewhat important
14%
Not important
5%
View Results
PHARM EXEC GLOBAL DIGEST
Pharmaceutical Executive Digest Europe Have you read the latest issue of Pharmaceutical Executive Digest Europe yet?
Click here if you haven't. Click here to receive the Digest into your inbox every week.
Click here